全文获取类型
收费全文 | 9710篇 |
免费 | 810篇 |
国内免费 | 105篇 |
学科分类
医药卫生 | 10625篇 |
出版年
2023年 | 84篇 |
2022年 | 69篇 |
2021年 | 259篇 |
2020年 | 184篇 |
2019年 | 292篇 |
2018年 | 323篇 |
2017年 | 225篇 |
2016年 | 208篇 |
2015年 | 316篇 |
2014年 | 404篇 |
2013年 | 530篇 |
2012年 | 726篇 |
2011年 | 833篇 |
2010年 | 507篇 |
2009年 | 386篇 |
2008年 | 587篇 |
2007年 | 529篇 |
2006年 | 555篇 |
2005年 | 528篇 |
2004年 | 479篇 |
2003年 | 386篇 |
2002年 | 355篇 |
2001年 | 248篇 |
2000年 | 204篇 |
1999年 | 179篇 |
1998年 | 63篇 |
1997年 | 53篇 |
1996年 | 37篇 |
1995年 | 63篇 |
1994年 | 51篇 |
1993年 | 52篇 |
1992年 | 121篇 |
1991年 | 94篇 |
1990年 | 89篇 |
1989年 | 53篇 |
1988年 | 57篇 |
1987年 | 65篇 |
1986年 | 32篇 |
1985年 | 40篇 |
1984年 | 46篇 |
1983年 | 32篇 |
1982年 | 25篇 |
1981年 | 19篇 |
1980年 | 18篇 |
1979年 | 26篇 |
1978年 | 17篇 |
1976年 | 20篇 |
1975年 | 18篇 |
1973年 | 17篇 |
1972年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 18 毫秒
1.
Lin Shu-I. Liao Feng-Ching Chiou Wei-Ru Lin Po-Lin Kuo Jen-Yuan Tsai Cheng-Ting Lee Ying-Hsiang 《Journal of interventional cardiac electrophysiology》2022,63(2):229-230
Journal of Interventional Cardiac Electrophysiology - 相似文献
2.
3.
Dongbing Lai Emma C. Johnson Sarah Colbert Gayathri Pandey Grace Chan Lance Bauer Meredith W. Francis Victor Hesselbrock Chella Kamarajan John Kramer Weipeng Kuang Sally Kuo Samuel Kuperman Yunlong Liu Vivia McCutcheon Zhiping Pang Martin H. Plawecki Marc Schuckit Jay Tischfield Leah Wetherill Yong Zang Howard J. Edenberg Bernice Porjesz Arpana Agrawal Tatiana Foroud 《Alcoholism, clinical and experimental research》2022,46(3):374-383
4.
Qiangsheng He Chongfei Huang Xiwen Qin Yuanyuan Yu Di Tang Junjie Huang Zi Chong Kuo Yuyao Ling Deli Mao Bin Xia Wenjing Li Kuiqing Lu Man Yang Yulong He Wenbo Meng Jinqiu Yuan Yihang Pan 《International journal of cancer. Journal international du cancer》2023,153(5):942-949
Recent epidemiological studies suggested that proton pump inhibitor (PPI) use was associated with an increased risk of biliary tract cancer (BTC), however, confounders were not adequately controlled. Our study aimed to evaluate PPI use and subsequent risk of BTC and its subtypes in three well-established cohorts. We conducted a pooled analysis of the subjects free of cancers in UK Biobank (n = 463 643), Nurses' Health Study (NHS, n = 80 235) and NHS II (n = 95 869). Propensity score weighted Cox models were used to estimate marginal HRs of PPIs use on BTC risk, accounting for potential confounders. We documented 284 BTC cases in UK Biobank (median follow-up: 7.6 years), and 91 cases in NHS and NHS II cohorts (median follow-up: 15.8 years). In UK biobank, PPI users had a 96% higher risk of BTC compared to nonusers in crude model (HR 1.96, 95% CI 1.44-2.66), but the effect was attenuated to null after adjusting for potential confounders (HR 0.95, 95% CI 0.60-1.49). PPI use was not associated with risk of BTC in the pooled analysis of three cohorts (HR 0.93, 95% CI 0.60-1.43). We also observed no associations between PPI use with risk of intrahepatic (HR 1.00, 95% CI 0.49-2.04), extrahepatic bile duct (HR 1.09, 95% CI 0.52-2.27) and gallbladder cancers (HR 0.66, 95% CI 0.26-1.66) in UK Biobank. In summary, regular use of PPIs was not associated with the risk of BTC and its subtypes. 相似文献
5.
目的从细胞因子角度,探究人参败毒散多成分、多靶点、多途径抗新型冠状病毒肺炎(COVID-19)的作用机制。方法应用中药系统药理分析平台(TCMSP)收集人参败毒散中活性化合物,结合药物靶点数据库收集细胞因子风暴相关靶点,利用Cytoscape构建"药材-化合物-疾病靶点"网络。通过String和DAVID数据库对靶点的互作网络、GO功能和KEGG通路进行分析。结果人参败毒散"药材-活性化合物-疾病靶点"网络包括10种药材,211个活性成分和151个疾病靶点。互作网络发现人参败毒散抑制细胞因子风暴治疗COVID-19的靶点可能包含STAT3、MAPK1、NFκB1、PIK3CA、MAPK3、TNF、CXCR4、VEGFA、IL-6、IL-2等。GO功能分析发现上述靶点在生物功能方面涉及趋化性、类固醇代谢过程等;在分子功能方面涉及血红素结合、铁离子结合、氧结合等;在细胞组成方面涉及细胞表面、细胞膜等。KEGG通路富集发现上述靶点参与查加斯病通路、HIF-1信号通路、肿瘤坏死因子信号通路等的调控。结论人参败毒散可能通过调节趋化性细胞因子,增加血氧饱和度,抑制STAT、MAPK、NFκB、PIK3K、IL-6等炎症相关信号通路,实现多成分-多靶点-多途径抑制细胞因子风暴形成的抗COVID-19作用。 相似文献
6.
Kuo‐Hwa Chiang Jiunn‐Min Shieh Chih‐Jie Shen Ting‐Wei Chang Pei‐Ting Wu Jinn‐Yuan Hsu Jhih‐Peng Tsai Wen‐Chang Chang Ben‐Kuen Chen 《Cancer science》2020,111(6):2004-2015
Epidermal growth factor receptor (EGFR) expression and activation are the major causes of metastasis in cancers such as head and neck squamous cell carcinoma (HNSCC). However, the reciprocal effect of EGF‐induced COX‐2 and angiopoietin‐like 4 (ANGPTL4) on HNSCC metastasis remains unclear. In this study, we revealed that the expression of ANGPTL4 is essential for COX‐2‐derived prostaglandin E2 (PGE2)‐induced tumor cell metastasis. We showed that EGF‐induced ANGPTL4 expression was dramatically inhibited with the depletion and inactivation of COX‐2 by knockdown of COX‐2 and celecoxib treatment, respectively. Prostaglandin E2 induced ANGPTL4 expression in a time‐ and dose‐dependent manners in various HNSCC cell lines through the ERK pathway. In addition, the depletion of ANGPTL4 and MMP1 significantly impeded the PGE2‐induced transendothelial invasion ability of HNSCC cells and the binding of tumor cells to endothelial cells. The induction of molecules involved in the regulation of epithelial‐mesenchymal transition was also dependent on ANGPTL4 expression in PGE2‐treated cells. The depletion of ANGPTL4 further blocked PGE2‐primed tumor cell metastatic seeding of lungs. These results indicate that the EGF‐activated PGE2/ANGPTL4 axis enhanced HNSCC metastasis. The concurrent expression of COX‐2 and ANGPTL4 in HNSCC tumor specimens provides insight into potential therapeutic targets for the treatment of EGFR‐associated HNSCC metastasis. 相似文献
7.
8.
9.
10.
Clinical Rheumatology - Elevated IL-17 levels with higher Th17 numbers are identified in systemic lupus erythematosus (SLE). STAT3 signaling plays a crucial role in the Th17 generation, and SOCS3... 相似文献